Study conducted by 13 organisations found that in govt hospitals, direct median total cost for treating bloodstream infections triggered by antimicrobial-resistant bacteria was Rs 89,377.
Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Study by scientists associated with ICMR, Cambridge University and Christian Medical College (CMC), Vellore, was published Tuesday in the Journal of Epidemiology and Global Health.
Findings published Tuesday also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050.
Islamabad-based think-tank PICSS's new report says Pakistan saw 'pronounced escalation' in violence last year, with 3,413 conflict-related deaths compared to 1,950 in previous year.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS